Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference
Rhea-AI Summary
Clover Health (NASDAQ:CLOV) announced that CFO Peter Kuipers will present at the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, at 11:00 a.m. Eastern Time.
Investors can access both the live webcast and replay of the presentation through Clover Health's investor relations website at investors.cloverhealth.com.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CLOV gained 3.54%, reflecting a moderate positive market reaction. Argus tracked a peak move of +10.2% during that session. Our momentum scanner triggered 26 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $59M to the company's valuation, bringing the market cap to $1.72B at that time.
Data tracked by StockTitan Argus on the day of publication.
WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 11:00 a.m. Eastern Time.
A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence and Congestive Heart Failure, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
FAQ
When is Clover Health (CLOV) presenting at the Canaccord Genuity Growth Conference?
Who will represent Clover Health (CLOV) at the Canaccord Genuity Conference?
How can investors access Clover Health's (CLOV) Canaccord conference presentation?
What is the Canaccord Genuity conference where Clover Health (CLOV) is presenting?
